Back
Guided Therapeutics, Inc. 10K Form
Buy
61
GTHP
Guided Therapeutics, Inc.
Last Price:
$0.32
Seasonality Move:
-8.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-13 | 10Q | GTHP/Guided Therapeutics, Inc. Quarterly |
| 2023-08-10 | 10Q | GTHP/Guided Therapeutics, Inc. Quarterly |
| 2023-05-15 | 10Q | GTHP/Guided Therapeutics, Inc. Quarterly |
| 2022-11-14 | 10Q | GTHP/Guided Therapeutics, Inc. Quarterly |
| 2022-08-15 | 10Q | GTHP/Guided Therapeutics, Inc. Quarterly |
| 2022-05-16 | 10Q | GTHP/Guided Therapeutics, Inc. Quarterly |
Receive GTHP News And Ratings
See the #1 stock for the next 7 days that we like better than GTHP
GTHP Financial Statistics
Sales & Book Value
| Annual Sales: | $7K |
|---|---|
| Cash Flow: | $-279K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.09 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.03870 |
|---|---|
| Net Income (TTM): | $-2.6M |
| Gross Margin: | $-93K |
| Return on Equity: | 0% |
| Return on Assets: | -242.05% |
Guided Therapeutics, Inc. Earnings Forecast
Key Guided Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for GTHP is -1,328.57%.
-
The Selling, General & Administrative Expenses for GTHP have been equal to 22,628.57% of Gross Profit Margin.
-
The Research & Development expenses have been 7,514.29% of Revenue.
-
The Net Earning history of GTHP is -34,528.57% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 12 years.
Guided Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | GTHP |
| CUSIP: | 40171F |
| Website: | guidedinc.com |
Debt
| Debt-to-Equity Ratio: | -0.43 |
|---|---|
| Current Ratio: | 0.12 |
| Quick Ratio: | 0.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GTHP Technical Analysis vs Fundamental Analysis
Buy
61
Guided Therapeutics, Inc. (GTHP)
is a Buy
Is Guided Therapeutics, Inc. a Buy or a Sell?
-
Guided Therapeutics, Inc. stock is rated a BuyThe current Guided Therapeutics, Inc. [GTHP] share price is $0.32. The Score for GTHP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.